Patient and physician expectations of add-on treatment with golimumab for rheumatoid arthritis: relationships between expectations and clinical and quality of life outcomes.
(2014) Arthritis Care & Research — Vol. 66, n° 12, p. 1799-1807 (2014)
Files
pdfdocument.pdf
Restricted Access - Adobe PDF
- 823.12 KB
Details
- Authors
- Abstract
- Rheumatoid arthritis (RA) management involves improving clinical outcomes and quality of life (QOL). Golimumab is used as add-on therapy for patients who have failed disease-modifying antirheumatic drugs (DMARDs). This GO-MORE subanalysis investigated relationships between patient and physician expectations and outcomes.
- Affiliations
Citations
Dasgupta, B., Combe, B., Louw, I., Wollenhaupt, J., Zerbini, C. A. F., Beaulieu, A., Schulze-Koops, H., Durez, P., Wolff, V., Yao, R., Weng, H. H., Govoni, M., & Vastesaeger, N. (2014). Patient and physician expectations of add-on treatment with golimumab for rheumatoid arthritis: relationships between expectations and clinical and quality of life outcomes. Arthritis Care & Research, 66(12), 1799-1807. https://doi.org/10.1002/acr.22371 (Original work published 2014)